NCT05659160 Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2
| NCT ID | NCT05659160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Huanhu Hospital |
| Condition | Stroke, Acute Ischemic |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2021-11-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2021-11-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to create a comprehensive, real-world, multi-center observational registry of consecutive patients admitted to hospitals with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO), who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).
Eligibility Criteria
Inclusion Criteria: 1. Patient admitted from Jan. 1st 2018 to Jan. 1st 2028; 2. Age ≥ 18; 3. Ischemic stroke confirmed by head CT or MRI; 4. Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2); 5. Patients receiving either endovascular therapy or best medical treatment; Exclusion Criteria: \- None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05659160 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Acute Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05659160 currently recruiting?
Yes, NCT05659160 is actively recruiting participants. Contact the research team at drweiming@163.com for enrollment information.
Where is the NCT05659160 trial being conducted?
This trial is being conducted at Tianjin, China, Tianjin, China, Tianjin, China, Tianjin, China.
Who is sponsoring the NCT05659160 clinical trial?
NCT05659160 is sponsored by Tianjin Huanhu Hospital. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.